Calpainopathy (LGMD2A) in Croatia: Molecular and haplotype analysis

Croatian Medical Journal

Volumn 46, Issue 4, 2005, Pages 657-663

  Milić, Astrid ^a   Canki Klain, Nina ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CALPAINOPATHY; CAPN3 GENE; CLINICAL ARTICLE; CROATIA; DNA FLANKING REGION; FEMALE; GENE; GENE MUTATION; GENETIC ANALYSIS; GENETIC COUNSELING; GENETIC DRIFT; HAPLOTYPE; HUMAN; LIMB GIRDLE MUSCULAR DYSTROPHY; MALE; MOLECULAR GENETICS; MULTIGENE FAMILY; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION;

CALPAIN; CROATIA; EPIDEMIOLOGY, MOLECULAR; FEMALE; HAPLOTYPES; HUMANS; MALE; MUSCULAR DYSTROPHIES; PEDIGREE; PROSPECTIVE STUDIES;

EID: 24344474502     PISSN: 03539504     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Erb W. About "juvenile form" of progressive muscle atrophy, its correlation to muscle pseudohypertrophy [in German]. Dtsch Arch Klin Med. 1884;34:467-519.
2. Bushby KM, Beckmann JS. The limb-girdle muscular dystrophies - proposal for a new nomenclature. Neuromuscul Disord. 1995;5:337-43.
3. Beckmann JS, Richard I, Hillaire D, Broux O, Antignac C, Bois E, et al. A gene for limb-girdle muscular dystrophy maps to chromosome 15 by linkage. C R Acad Sci III. 1991;312:141-8.
4. Allamand V, Broux O, Richard I, Fougerousse F, Chiannilkulchai N, Bourg N, et al. Preferential localization of the limb-girdle muscular dystrophy type 2A gene in the proximal part of a 1-cM 15q15.1-q15.3 interval. Am J Hum Genet. 1995;56:1417-30.
5. Richard I, Broux O, Allamand V, Fougerousse F, Chiannilkulchai N, Bourg N, et al. Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell. 1995;81:27-40.
6. Fanin M, Nascimbeni AC, Fulizio L, Angelini C. The frequency of limb girdle muscular dystrophy 2A in northeastern Italy. Neuromuscul Disord. 2005;15:218-24.
7. Fanin M, Fulizio L, Nascimbeni AC, Spinazzi M, Piluso G, Ventriglia VM, et al. Molecular diagnosis in LGMD2A: mutation analysis or protein testing? Hum Mutat. 2004;24:52-62.
8. Richard I, Brenguier L, Dincer P, Roudaut C, Bady B, Burgunder JM, et al. Multiple independent molecular etiology for limb-girdle muscular dystrophy type 2A patients from various geographical origins. Am J Hum Genet. 1997;60:1128-38.
9. Richard I, Roudaut C, Saenz A, Pogue R, Grimbergen JE, Anderson LV, et al. Calpainopathy-a survey of mutations and polymorphisms. Am J Hum Genet. 1999;64: 1524-40.
10. Chae J, Minami N, Jin Y, Nakagawa M, Murayama K, Igarashi F, et al. Calpain 3 gene mutations: genetic and clinico-pathologic findings in limb-girdle muscular dystrophy. Neuromuscul Disord. 2001;11:547-55.
11. Milic A, Piluso G, Ventriglia V, D'Amico F, Kovac B, Trlaja A, et al. Mutation spectrum of CAPN3 gene in LGMD 2A patients in Croatia. Eur J Hum Genet. 2002; 10 Suppl 1:181.
12. Chrobakova T, Hermanova M, Kroupova I, Vondracek P, Marikova T, Mazanec R, et al. Mutations in Czech LGMD2A patients revealed by analysis of calpain3 mRNA and their phenotypic outcome. Neuromuscul Disord. 2004;14:659-65.
13. Anderson LV, Davison K, Moss JA, Richard I, Fardeau M, Tome FM, et al. Characterization of monoclonal antibodies to calpain 3 and protein expression in muscle from patients with limb-girdle muscular dystrophy type 2A. Am J Pathol. 1998;153:1169-79.
14. Talim B, Ognibene A, Mattioli E, Richard I, Anderson LV, Merlini L. Normal calpain expression in genetically confirmed limb-girdle muscular dystrophy type 2A. Neurology. 2001;56:692-3.
15. Canki-Klain N, Zurak N. Strategy of genetic and epidemiological study of muscular dystrophies in Croatia. Pediatrica Croatica. 1997;41:75-9.
16. Canki-Klain N, Milic A, Kovac B, Trlaja A, Grgicevic D, Zurak N, et al. Prevalence of the 550delA mutation in calpainopathy (LGMD 2A) in Croatia. Am J Med Genet. 2004;125:152-6.
17. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.
18. Pogoda TV, Krakhmaleva IN, Lipatova NA, Shakhovskaya NI, Shishkin SS, Limborska SA. High incidence of 550delA mutation of CAPN3 in LGMD2 patients from Russia. Hum Mutat. 2000;15:295.
19. Todorova A, Georgieva B, Tournev I, Kremensky I. LGMD 2A in Bulgarian patients-mutations and polymorphisms in CAPN3 gene. Eur J Hum Genet. 2003;11 Suppl 1:206.
20. Balci B, Talim B, Haliloglu G, Aurino S, Akcoren Z, Leturcq F, et al. Calpain-3 mutations in Turkey: 10 years experience. Neuromuscul Disord. 2004;14:606.
21. Meznaric-Petrusa MM, Zidar J, Zupancic N, Fanin M, Angelini C, Piluso G, et al. Clinical, molecular and genetic features of calpainopathy in Slovenia. Neuromuscul Disord. 2002;12:731.
22. de Paula F, Vainzof M, Passos-Bueno MR, de Cassia M Pavanello R, Matioli SR, V B Anderson L, et al. Clinical variability in calpainopathy: what makes the difference? Eur J Hum Genet. 2002;10:825-32.
23. Topaloglu H, Dincer P, Richard I, Akcoren Z, Alehan D, Ozme S, et al. Calpain-3 deficiency causes a mild muscular dystrophy in childhood. Neuropediatrics. 1997; 28:212-6.